Biomet files to sell shares in IPO to pay down debt

Indiana-based Biomet Group Inc., a closely held maker of orthopedic medical devices whose shareholders include Blackstone Group LP, filed Friday to sell shares in a U.S. initial public offering to pay down debt.

Biomet, whose owners also include TPG Capital and Goldman Sachs Group Inc., had revenue of more than $3 billion in its latest fiscal year, according to the U.S. regulatory filing. The Warsaw-based company listed $100 million as the possible size of the deal.

The proceeds will be used toward paying debt, the filing said. The company’s net debt was 5.2 times earnings before interest, taxes, depreciation and amortization last year, compared with an average of 0.7 times for larger peers including Stryker Corp., Smith & Nephew Plc and Zimmer Holdings Inc., according to Bloomberg Industries analysts.

Bank of America Corp., Citigroup Inc. and JPMorgan Chase & Co. are among banks managing the IPO, the filing said. Biomet will trade under the symbol BMET.

Biomet reported net income of $36 million for the six months ended Nov. 30, compared with a net loss of $97.7 million a year earlier. Total debt as of Nov. 30 was $5.9 billion.

The company was publicly traded until 2007 when it was acquired by the group of private equity firms under the name LVB Acquisition Inc. The filing said LVB will change its name to Biomet Group Inc. ahead of the IPO’s completion.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.